What is CBLL's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.91B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CBLL?

P/E (TTM) is n/a and 52-week range is $10.85 to $25.63 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CBLL figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for CBLL?

The company profile lists revenue (TTM) near $102M, net income (TTM) near $-6.58B, EPS (TTM) near $-1.76 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Ceribell Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Sunnyvale, California, US, 37.9M shares outstanding, ISIN US15678C1027 when available from company profile and filing metadata.

Ceribell Inc

$CBLL

Health Care · Health Care Equipment & Supplies

Run Scenarios

$23.63

+2.07%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 327 full-time employees. The company went IPO on 2024-10-11. The firm has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

Employees

327

Website

ceribell.com/

IPO

2024-10-11

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)